Simpson Thacher recently represented Catalent Pharma Solutions, Inc. in connection with a new $275,000,000 senior unsecured term loan facility. The proceeds of the senior unsecured term loan facility will be used to redeem all of the Company’s outstanding 9.5%/10.25% Senior PIK-Election Notes due 2015.
Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products.
The Simpson Thacher team included: Alden Millard, Brian Gluck, Mike Vernace and Adam Moss (Credit); and Ed Tolley, Brad Goldberg and Xavier Kowalski (Capital Markets).
